POS-292 OPHTHALMOLOGICAL EFFECTS OF ROXADUSTAT IN THE TREATMENT OF ANEMIA IN DIALYSIS-DEPENDENT AND NON–DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE PATIENTS: FINDINGS FROM TWO PHASE 3 STUDIES
Y. Sepah,
Q.D. Nguyen,
Y. Yamaguchi,
T. Otsuka,
Y. Majikawa,
M. Reusch,
T. Akizawa
Affiliations
Y. Sepah
Byers Eye Institute, Stanford School of Medicine, Stanford, United States
Q.D. Nguyen
Byers Eye Institute, Stanford School of Medicine, Stanford, United States
Y. Yamaguchi
Astellas Pharma- Inc., Japan-Asia Data Science, Tokyo, Japan
T. Otsuka
Astellas Pharma- Inc., Japan-Asia Clinical Development, Tokyo, Japan
Y. Majikawa
Astellas Pharma- Inc., Japan-Asia Clinical Development, Tokyo, Japan
M. Reusch
Astellas Pharma Europe B.V., TA Medical Specialties, Leiden, Netherlands
T. Akizawa
Showa University School of Medicine, Nephrology, Tokyo, Japan
